Status:
UNKNOWN
Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Congenital or Acquired Hypopituitarism
Eligibility:
All Genders
10-17 years
Brief Summary
Relatively little is known about the quality of life (QOL) of patients with hypopituitarism, particularly children. Quality of life studies have mostly focused on improvements following the initiation...
Detailed Description
Objectives: * Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or ...
Eligibility Criteria
Inclusion
- Age 10-17 years
- Multiple or isolated pituitary hormone deficiency
- Deficiency diagnosed for a least 6 months
Exclusion
- Isolated growth hormone deficiency with normal MRI findings and/or no previous irradiation of the hypothalamo-pituitary region and/or no known genetic cause.
- Secondary pituitary deficiency due to a secreting adenoma
- Inability to complete the questionnaire (intellectual disability, low French language proficiency)
- No health coverage
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05403255
Start Date
July 1 2022
End Date
January 1 2024
Last Update
June 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux Marseille
Marseille, Bouches-du-Rhône, France, 13354